Search Results
Search for other papers by Chiung-Kuei Huang in
Google Scholar
PubMed
Search for other papers by Soo Ok Lee in
Google Scholar
PubMed
Department of Medicine, Case Cardiovascular Institute Research Institute, Case Western Reserve University, Cleveland, OH, USA
Search for other papers by Eugene Chang in
Google Scholar
PubMed
Search for other papers by Haiyan Pang in
Google Scholar
PubMed
Sex Hormone Research Center, China Medical University/Hospital, Taichung, Taiwan
Search for other papers by Chawnshang Chang in
Google Scholar
PubMed
) has been applied and patients indeed showed improvement in heart functions ( Vigna & Bergami 2005 , Kang et al . 2012 ). Due to this dilemma, recent studies were shifted to the effects of the androgen receptor (AR) rather than androgens on CVDs, as
Search for other papers by Verónica Torres-Estay in
Google Scholar
PubMed
Search for other papers by Daniela V Carreño in
Google Scholar
PubMed
Search for other papers by Ignacio F San Francisco in
Google Scholar
PubMed
Search for other papers by Paula Sotomayor in
Google Scholar
PubMed
Departamento de Fisiología, Urología, Center for Integrative Medicine and Innovative Sciences, Department of Urology, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile
Search for other papers by Alejandro S Godoy in
Google Scholar
PubMed
Search for other papers by Gary J Smith in
Google Scholar
PubMed
Androgen receptor and vascular cells Androgens are male sex hormones that are critical for the development and maintenance of the male reproductive system. Given the extensive role of androgens in normal physiology, abnormal androgen activity has
Search for other papers by Kelly Coffey in
Google Scholar
PubMed
Search for other papers by Craig N Robson in
Google Scholar
PubMed
Introduction The androgen receptor (AR; Fig. 1 ) is a steroid hormone receptor that plays a critical role in prostate cancer (PC) progression and development. In addition, it can also cause spinal bulbar muscular dystrophy (commonly referred to as
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Dieuwertje C E Spaanderman in
Google Scholar
PubMed
Search for other papers by Mark Nixon in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Jacobus C Buurstede in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Hetty H C M Sips in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Maaike Schilperoort in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Eline N Kuipers in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Emma A Backer in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Sander Kooijman in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Patrick C N Rensen in
Google Scholar
PubMed
Search for other papers by Natalie Z M Homer in
Google Scholar
PubMed
Institute for Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Search for other papers by Brian R Walker in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Onno C Meijer in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Jan Kroon in
Google Scholar
PubMed
al . 2010 ). Such sexually dimorphic effects could possibly be explained by glucocorticoid interactions with sex hormone signaling, e.g. androgen receptor (AR) activity. AR signaling is known to regulate physiological processes like adipose tissue
Search for other papers by Mutaz Musa in
Google Scholar
PubMed
Search for other papers by Shannon M Fernando in
Google Scholar
PubMed
Search for other papers by Diptendu Chatterjee in
Google Scholar
PubMed
Institute of Medical Science, Department of Psychology, University of Toronto, Toronto, Ontario, Canada M5S 3G3
Search for other papers by D Ashley Monks in
Google Scholar
PubMed
-type (Wt) or vehicle (VEH)-treated females, show increased specific activity of complexes I–IV of the respiratory chain measured in nmol/min per mg protein. L141 females, which overexpress androgen receptor to a greater extent, show greater increases in
Neuroscience Research Center, Hebei Medical University, Shijiazhuang, Hebei, China
Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University, Shijiazhuang, Hebei, China
Search for other papers by Yizhou Zhang in
Google Scholar
PubMed
Search for other papers by Meiqin Chen in
Google Scholar
PubMed
Neuroscience Research Center, Hebei Medical University, Shijiazhuang, Hebei, China
Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University, Shijiazhuang, Hebei, China
Search for other papers by Huan Chen in
Google Scholar
PubMed
Search for other papers by Shixiong Mi in
Google Scholar
PubMed
Neuroscience Research Center, Hebei Medical University, Shijiazhuang, Hebei, China
Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University, Shijiazhuang, Hebei, China
Search for other papers by Chang Wang in
Google Scholar
PubMed
Search for other papers by Hongchun Zuo in
Google Scholar
PubMed
Search for other papers by Leigang Song in
Google Scholar
PubMed
Neuroscience Research Center, Hebei Medical University, Shijiazhuang, Hebei, China
Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University, Shijiazhuang, Hebei, China
Search for other papers by Juan Du in
Google Scholar
PubMed
Neuroscience Research Center, Hebei Medical University, Shijiazhuang, Hebei, China
Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University, Shijiazhuang, Hebei, China
Search for other papers by Huixian Cui in
Google Scholar
PubMed
Neuroscience Research Center, Hebei Medical University, Shijiazhuang, Hebei, China
Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University, Shijiazhuang, Hebei, China
Search for other papers by Sha Li in
Google Scholar
PubMed
disorders ( Bianchi et al. 2020 , Li et al. 2020 ). However, there is a pressing need to better understand the mechanisms elucidating the effects of androgen on cognition. The androgen receptor (AR), which acts as a transcriptional regulator, mediates
Search for other papers by J M Bentel in
Google Scholar
PubMed
Search for other papers by W D Tilley in
Google Scholar
PubMed
Introduction
Prostate cancer constitutes a major health issue in Western countries where it is now the most frequently diagnosed invasive tumour and second leading cause of cancer deaths (Wingo et al. 1995). Androgen action in prostate cancers, as in the normal prostate gland and other target organs, is mediated by the androgen receptor (AR), a ligand-activated nuclear transcription factor that is a member of the steroid/thyroid hormone receptor gene superfamily (O'Malley 1990, Truss & Beato 1993). Although the human AR has only recently been cloned (Chang et al. 1988, Lubahn et al. 1988, Trapman et al. 1988, Tilley et al. 1989), specific actions of androgens on the growth, differentiation and function of the prostate gland were elucidated early this century. In 1941, Huggins and Hodges demonstrated that, similar to non-malignant prostate, prostate cancers were androgen-responsive and that tumour regression was evident following removal of testicular androgens by castration. More than
Search for other papers by Mahsa Hamzeh in
Google Scholar
PubMed
Department of Pharmacology and Therapeutics, Department of Obstetrics and Gynecology, McGill University, McIntyre Medical Sciences Building, 3655 Promenade Sir-William-Osler, Room 104, Montréal, Québec, Canada H3G 1Y6
Search for other papers by Bernard Robaire in
Google Scholar
PubMed
their effects by diffusing through the plasma membrane and binding to intracellular androgen receptors (ARs). The AR functions as a ligand-inducible transcription factor modulating transcription of target genes ( He et al . 1999 , Heinlein & Chang
Search for other papers by Ioannis Simitsidellis in
Google Scholar
PubMed
Search for other papers by Arantza Esnal-Zuffiaure in
Google Scholar
PubMed
Search for other papers by Olympia Kelepouri in
Google Scholar
PubMed
Search for other papers by Elisabeth O’Flaherty in
Google Scholar
PubMed
Search for other papers by Douglas A Gibson in
Google Scholar
PubMed
Search for other papers by Philippa T K Saunders in
Google Scholar
PubMed
Introduction Androgens are pleiotropic hormones which bind with high affinity and specificity to androgen receptors (ARs) to regulate both reproductive and other tissues. In the uterus, androgen-target cells include stromal fibroblasts and
Department of Endocrinology, Free University Amsterdam, 1007 MB, The Netherlands
Department of Hematology, University of Liège, 4000 Sart Tilman, Belgium
Search for other papers by Guy G T’Sjoen in
Google Scholar
PubMed
Department of Endocrinology, Free University Amsterdam, 1007 MB, The Netherlands
Department of Hematology, University of Liège, 4000 Sart Tilman, Belgium
Search for other papers by Yves Beguin in
Google Scholar
PubMed
Department of Endocrinology, Free University Amsterdam, 1007 MB, The Netherlands
Department of Hematology, University of Liège, 4000 Sart Tilman, Belgium
Search for other papers by Els Feyen in
Google Scholar
PubMed
Department of Endocrinology, Free University Amsterdam, 1007 MB, The Netherlands
Department of Hematology, University of Liège, 4000 Sart Tilman, Belgium
Search for other papers by Robert Rubens in
Google Scholar
PubMed
Department of Endocrinology, Free University Amsterdam, 1007 MB, The Netherlands
Department of Hematology, University of Liège, 4000 Sart Tilman, Belgium
Search for other papers by Jean-Marc Kaufman in
Google Scholar
PubMed
Department of Endocrinology, Free University Amsterdam, 1007 MB, The Netherlands
Department of Hematology, University of Liège, 4000 Sart Tilman, Belgium
Search for other papers by Louis Gooren in
Google Scholar
PubMed
et al. (1997) . The mechanisms by which androgens exert these effects have not been elucidated. It has been suggested that androgen action on erythropoiesis is mediated by a nuclear androgen receptor ( Claustres & Sultan 1988 ). Administration